Popular science talk titled ‘Honey I shrunk the doctor!’ given at the Hub Science in Athens, Greece
The Hub Science invited Kostas for a public outreach lecture on the use of nanotechnology in Medicine, focusing on the ethical dilemmas that often surround its practice.
Nanomedicine Lab selected for Frontiers Scientists Workshop by Korean Academy of Science & Technology (KAST)
Kostas participates at the Korean Academy of Science & Technology (KAST) 5th Frontiers Scientists Workshop on ‘Chemistry for Innovations of Materials and Biomedicine’. Other speakers included Luis Brus (Columbia), Cees Dekker (Delft), Maxime Dahan (Institute Curie) and Joachim Spatz (Max Plank) among prominent Korean scientists such as Jinwoo Cheon (Yonsei) and was attended by the President of KAST and the Korean Ambassador to the UK.
Nanomedicine Lab affiliates with AstraZeneca and the University of Manchester North-West Centre for Advanced Drug Delivery (NoWCADD)
Read Press Release
The University of Manchester and AstraZeneca plc. have entered into a strategic alliance to develop cutting-edge technologies designed to enhance the way drugs work by development of advanced drug delivery technologies. NoWCADD will be housed at Manchester Pharmacy School with the Nanomedicine Lab as an affiliate partner.
Irene wins best oral presentation prize at the UCL School of Pharmacy PhD Research Day
Her lecture titled “Reprogramming the skeletal muscle to pluripotency in vivo” was awarded the top prize (and 100 pounds!) at the PhD Research Day that took place on the 19th of September at the UCL School of Pharmacy. She is the only graduate student from the Nanomedicine Lab to ever win both the poster and oral presentation awards during the course of their studies. Congratulations Irene!
Mariarosa presents at Translational Nanomedicine International Meeting 2014
Read the programme
Dr Mariarosa Mazza presented a talk on ‘Peptide Nanofibers for siRNA delivery in specific brain region’ at the Translational Nanomedicine International Meeting 2014 held in Angers, France from 27th – 29th August 2014.
Zahraa is featured as an invited speaker at the Academy of Pharmaceutical Science Annual meeting themed: ‘The Science of Medicines’
Read Session Profile
The APS are pleased to announce a talk from Dr Zahraa Al-Ahmady, from Nanomedicines Lab on Theranostic design at the Pharm Sci 2014 Conference on Monday 8th September 2014.
Nanomedicine Lab contributes to Graphene Week 2014 in Sweden
Kostas talking about the emergence of graphene in biomedicine during Graphene Week 2014
Kostas was invited to deliver a plenary talk to some 450 researchers from all over the world working on graphene and related materials who gathered in Gothenburg, Sweden to take part in Graphene Week 2014. He spoke about the emergent field of graphene in biomedicine and provided a snapshot of where graphene research stands at the moment in this field.
During Graphene Week 2014, Chalmers University, the Graphene Flagship and the Universeum (largest science museum in Scandinavia) inaugurated a new installation and exhibit dedicated to graphene. Kostas explained the two areas relevant to medicine featured in the Graphene Exhibition at the Universeum.
Mariarosa presents talk at the Nanomedicine 2014 Conference
Dr Mariarosa Mazza presented a talk on ‘Nanoparticle-mediated siRNA gene silencing against brain disorders’ at the British Society of Nanomedicine conference titled Nanomedicine 2014 held in Edinburgh between 25-27 March 2014.
Neus and Zahraa give talks at the 9th European Workshop on Particulate Systems in Nanomedicine
Dr Neus Lozano Valdes and Dr Zahraa Al-Ahmady gave talks at the 9th European Workshop on Particulate Systems in Nanomedicine (EWPS) held in Utrecht (The Netherlands), 13-14 March 2014.
Dhifaf wins best poster prize at Postgraduate Poster Day
Mrs Dhifaf Jasmin won the best poster prize awards (Jury and Peer) during the Postgraduate Poster Day at the Institute of Inflammation & Repair, School of Medicine, University of Manchester in January 2014. Her work on the transformation of graphene oxide for biomedical applications is currently in progress.